Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 526-550 of 798 matching filings.

Per page
25
Current page
22
4

FORM 4 SUBMISSION

Filing date
27 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
27 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
17 Jun 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-231326

FORM S-8

Filing date
09 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
09 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36912

DEFA14A

Filing date
26 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36912

DEF 14A

Filing date
26 Apr 2019
Reporting date
17 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
22 Mar 2019
Reporting date
21 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Mar 2019
Reporting date
26 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
08 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Mar 2019
Reporting date
07 Mar 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36912

CIDARA THERAPEUTICS, INC. 2018 FORM 10-K

Filing date
28 Feb 2019
Reporting date
31 Dec 2018
Next action
Verify source filing
8-K File 001-36912

FORM 8-K

Filing date
28 Feb 2019
Reporting date
28 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A filing

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
14 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

SC 13G/A

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G

Filing date
13 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88806

AMENDMENT NO. 1

Filing date
11 Feb 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .